Researchers have identified how proteins that play a key role in Alzheimer’s disease are linked in a pathway that controls its progression, and that drugs targeting this pathway may be a potential new way of treating the disease.
Forty million people worldwide are living with Alzheimer’s and this is only set to increase. But tiny brains grown in culture could help scientists learn more about this mysterious disease – and test new drugs.
Innovative way to study Alzheimer's disease developed by Cambridge scientists.
Research paves way for innovative techniques to explore disease as diverse as autism and Alzheimer’s.
© 2024 University of Cambridge